Andrew Hantel, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype (NCT07341867) | Andrew Hantel, MD | 2026-07-30 |
Track Andrew Hantel, MD automatically
Every clearance here is in the API, with alerts when new ones post.